PharmaAnalytica offers a full spectrum of testing services and solutions to enable our customers in the pharmaceutical industries worldwide to research, develop, discover and produce innovative drug products safely and effectively.
Small Molecule Drugs
Biologics
Natural Products
Inorganic & Organometallic Drugs
Nucleic Acid Therapeutics
Cell & Gene Therapy
Systematically identify and prioritize novel therapeutic targets with high clinical and commercial potential.
Learn more
Identify and confirm bioactive compounds' target-specific efficacy through biochemical and cellular assays.
Evaluate and optimize hit compounds for efficacy, selectivity, and drug-like properties to identify promising lead candidates for further development.
Ensure the identity, purity, and compatibility of active pharmaceutical ingredients (APIs) and their inactive components through techniques like HPLC, DSC, and dissolution testing.
Dedicated to revealing molecular structures, crystal forms, thermal behaviors, particle morphologies, and physicochemical properties of drugs and formulations. It supports structural identification, polymorphism analysis, material stability evaluation, and micro–nano morphology characterization, providing key data for drug design, formulation development, and regulatory compliance.
Focuses on the separation, purification, and quantitative/qualitative analysis of complex drug components. These techniques offer high resolution and sensitivity for identifying impurities, quantifying active pharmaceutical ingredients (APIs), analyzing degradation products, and ensuring the purity and consistency of pharmaceutical samples throughout R&D and quality control.
Focuses on nucleic acid amplification, sequencing, and molecular-level identification. It enables highly sensitive detection and sequence analysis of genes, pathogens, and nucleic acid biomarkers, supporting molecular diagnostics, gene therapy characterization, quality control of nucleic acid drugs, and biopharmaceutical safety evaluation with high specificity and throughput.
Specializes in analyzing biomolecular interactions, protein functions, and metabolic profiles. It supports target validation, drug-receptor binding kinetics, antibody characterization, proteomic and metabolomic profiling, and immuno-based quantitative detection, which are essential for biologic drug development, pharmacodynamics research, and biomarker discovery.
Performs cell-level functional analysis, dynamic monitoring, and high-resolution imaging. They enable real-time observation of cell viability, proliferation, apoptosis, and phenotypic changes, supporting drug efficacy screening, cytotoxicity evaluation, mechanism-of-action studies, and visual quantitative analysis in a cellular microenvironment.
